Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Drawing First Blood

Two experts to debate controversial topics in hematology and health care.
Drawing First Blood: How Long Should Patients With a Myeloproliferative Neoplasm Be Anticoagulated?
Leah Lawrence
Drawing First Blood: Will Menin Inhibitors Revolutionize the Treatment of AML?
Leah Lawrence
Which Inhibitor Should Be Used to Treat FLT3-Positive AML?
Emma Yasinski
Should Iron Deficiency Be Treated With Oral or IV Iron?
Emma Yasinski
Will Pola-R-CHP Be the New Standard Upfront Treatment for Diffuse Large B-Cell Lymphoma?
Are Hypomethylating Agents the Best First-Line Choice for Treating CMML?
Leah Lawrence
Which Modality Is Preferred in Hemophilia: Factor or Non-Factor Prophylaxis?
Kimberly J. Retzlaff
Clonal Cytopenia of Unknown Significance: To Treat or Not To Treat?
Kimberly Retzlaff
In Heparin-Induced Thrombocytopenia, Is Screening Four Extremities Better Than Screening Two?
Kimberly Retzlaff
Has ABIM Gone Too Far?
Is There Still a Need for Radiation Therapy in Hodgkin Lymphoma?
To Transplant or Not To Transplant in First Remission?
Rituximab or Splenectomy in Steroid-Resistant ITP Patients?
Is Fludarabine Dead in CLL?
For Anticoagulation in Cancer-Associated Thrombosis, Is Less More?
Should IVC Filters Still Be Inserted into Thrombosis Management Guidelines?
Optimal Timing of Transplant in Myeloma
Choosing Between Treatment Strategies for Patients With Acquired Hemophilia A
To Test or Not to Test: Is Pharmacogenomic Testing for Warfarin Valuable?
Should Patients With Myelodysplastic Syndromes Undergo Transplant?

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
Mid-November 2024

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals